Seelos Therapeutics, Inc. Retained Earnings
Seelos Therapeutics, Inc. had Retained Earnings of -$253.58 million as of 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-08-14
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$253.58M.
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$255.29M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$252.63M.
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$247.17M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2024-06-30 | -$253.58M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$255.29M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | -$252.63M 10-Q · filed 2024-08-14 | |
| 2023-09-30 | -$247.17M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$257.67M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | -$228.18M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | -$214.74M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $196.09M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $176.48M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $155.21M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | -$141.21M 10-K · filed 2023-03-10 | $141.21M 10-K · filed 2022-03-04 |
| 2021-09-30 | -$113.95M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | -$103.14M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | -$94.28M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $75.16M 10-K · filed 2022-03-04 | -$75.16M 10-K · filed 2021-03-11 |
| 2020-09-30 | -$68.71M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -$64.62M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | -$60.89M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | -$56.06M 10-K · filed 2021-03-11 | |
| 2019-09-30 | -$45.40M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | -$42.18M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | -$40.32M 10-Q · filed 2019-05-21 | |
| 2018-12-31 | -$4.81M 10-K · filed 2020-03-17 | -$325.23M 10-K · filed 2019-03-28 |
| 2018-09-30 | -$323.37M 10-Q · filed 2018-10-31 | |
| 2018-06-30 | -$320.54M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$318.26M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | -$315.99M 10-K · filed 2019-03-28 | |
| 2017-09-30 | -$313.54M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | -$309.71M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | -$308.24M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | -$316.31M 10-K · filed 2018-03-01 | |
| 2016-09-30 | -$316.01M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | -$314.72M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | -$311.38M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | -$308.88M 10-K · filed 2017-03-13 | |
| 2015-09-30 | -$306.54M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$301.51M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | -$296.26M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$289.85M 10-K · filed 2016-03-09 | |
| 2014-09-30 | -$272.56M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | -$269.45M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | -$271.33M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | -$268.07M 10-K · filed 2015-03-16 | |
| 2013-09-30 | -$266.72M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | -$263.74M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$259.80M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | -$251.13M 10-K · filed 2014-03-17 | |
| 2012-09-30 | -$231.49M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | -$229.00M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | -$224.07M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | -$219.36M 10-K · filed 2013-03-18 | -$219.36M 10-K · filed 2012-03-13 |
| 2011-09-30 | -$214.67M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$212.45M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | -$201.24M 10-K · filed 2012-03-13 |